Related Experiment Video
Updated: Aug 14, 2026
08:37
Isolation, Fixation, and Immunofluorescence Imaging of Mouse Adrenal Glands
Published on: October 2, 2018
Steroid biosynthesis in human adrenal tumors
R D'Agata1, S Malozowski, A Barkan
1Developmental Endocrinology Branch, NICHD, Bethesda, Maryland.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|August 1, 1987
Summary
Adrenal adenomas show higher 21-hydroxylase (21-OH) activity, while adrenal carcinomas exhibit less efficient steroidogenesis. This difference in enzyme activity may explain tumor size at clinical presentation.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Adrenal tumors present with diverse clinical features linked to varying steroidogenesis patterns.
- Understanding the enzymatic basis of these differences is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the in vitro activities of key steroidogenic enzymes in adrenal tumors.
- To compare enzyme activities between adrenal adenomas, carcinomas, and normal adrenal tissue.
Main Methods:
- In vitro enzyme activity assays for 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD), 17-hydroxylase (17-OH), 21-hydroxylase (21-OH), and 17-20 desmolase (17, 20-D).
- Analysis of 6 adrenal tumors (4 adenomas, 2 carcinomas) and normal human adrenal tissue.
Main Results:
- Adrenal adenomas demonstrated significantly increased 21-OH activity compared to normal tissue and adrenal carcinomas.
- Adrenal carcinomas showed reduced activities of 3 beta-HSD, 17-OH, and 17,20-D compared to controls, though not statistically significant.
- Enzyme activity patterns suggest less efficient overall steroidogenesis in adrenal carcinomas.
Conclusions:
- Elevated 21-OH activity in adenomas and reduced steroidogenic efficiency in carcinomas are key findings.
- These enzymatic differences may contribute to the clinical presentation and size of adrenal tumors, particularly carcinomas.
Related Concept Videos
01:31Hormones of the Adrenal Glands
Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
01:24Gonadal and Placental Hormones
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...